Paramyxoviruses: Pathogenesis, Vaccines, Antivirals, and Prototypes for Pandemic Preparedness

• Published in: The Journal of infectious diseases Vol. 228; no. Supplement_6; pp. S390 - S397
• Main Authors: Duprex, W Paul, Dutch, Rebecca Ellis
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 18.10.2023
• Subjects: Antiviral agents; Antiviral Agents - therapeutic use; Antiviral drugs; Henipavirus; Humans; Life cycles; Measles; Nipah Virus; Pandemics; Parainfluenza; Paramyxoviridae; Pathogenesis; Pathogens; Respiratory system; Vaccines; Viruses; Zoonoses; prototype pathogens; zoonosis; pandemic preparedness; paramyxovirus
• ISSN: 0022-1899; 1537-6613; 1537-6613
• DOI: 10.1093/infdis/jiad123

Abstract The Paramyxoviridae family includes established human pathogens such as measles virus, mumps virus, and the human parainfluenza viruses; highly lethal zoonotic pathogens such as Nipah virus; and a number of recently identified agents, such as Sosuga virus, which remain poorly understood. The high human-to-human transmission rate of paramyxoviruses such as measles virus, high case fatality rate associated with other family members such as Nipah virus, and the existence of poorly characterized zoonotic pathogens raise concern that known and unknown paramyxoviruses have significant pandemic potential. In this review, the general life cycle, taxonomic relationships, and viral pathogenesis are described for paramyxoviruses that cause both systemic and respiratory system–restricted infections. Next, key gaps in critical areas are presented, following detailed conversations with subject matter experts and based on the current literature. Finally, we present an assessment of potential prototype pathogen candidates that could be used as models to study this important virus family, including assessment of the strengths and weaknesses of each potential prototype.